Canagliflozin and Metformin Extended-Release Tablets and Inotuzumab ozogamicin Intravenous
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Inova
- Canagliflozin and Metformin Extended-Release Tablets-Inova 4/1 topical
- Canagliflozin and Metformin Extended-Release Tablets-Inova 8/2 topical
- Canagliflozin and Metformin Extended-Release Tablets-Inova ACT
- Canagliflozin and Metformin Extended-Release Tablets-Inrebic
- Canagliflozin and Metformin Extended-Release Tablets-Inspra
- Inotuzumab ozogamicin Intravenous-Canagliflozin and Metformin Tablets
- Inotuzumab ozogamicin Intravenous-Canakinumab
- Inotuzumab ozogamicin Intravenous-Canakinumab Subcutaneous
- Inotuzumab ozogamicin Intravenous-Canasa
- Inotuzumab ozogamicin Intravenous-Canasa Pac rectal
- Inotuzumab ozogamicin Intravenous-Canasa rectal